Clinical curative efficacy of inducing remission for the newly diagnosed aged AML patients by chemotherapy with IA and DA regimens
This study was aimed to explore the clinical efficacy and toxicity of idarubicin (IA regimen) and daunoru-bicin combined with cytarabine (DA regimen) for treating aged patients with AML as induction chemotherapy. The clinical data of 60 newly diagnosed AML aged patients treated with IA or DA regimen...
Saved in:
Published in | Zhongguo shi yan xue ye xue za zhi Vol. 22; no. 5; p. 1282 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | Chinese |
Published |
China
01.10.2014
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | This study was aimed to explore the clinical efficacy and toxicity of idarubicin (IA regimen) and daunoru-bicin combined with cytarabine (DA regimen) for treating aged patients with AML as induction chemotherapy. The clinical data of 60 newly diagnosed AML aged patients treated with IA or DA regimen were analyzed retrospectively. IA regimen group included 22 patients (8 male and 14 females with median age of 66 yrs), while the DA regimen group included 38 patients (20 males and 18 females with median age of 64 yrs). The complete remission rate, total effective rate and adverse effects after one chemotherapy course were compared. The results showed that the CR rate in IA regimen group was 63.63%, which was significantly higer than that in DA regimen group (31.58%) (P < 0.05). The total effective rate was 63.63% and 36.84% respectively in IA and DA regimen groups, there was significant difference between the two groups (P < 0.05). Both the hematological and non-hematological adverse effects were observed and no |
---|---|
AbstractList | This study was aimed to explore the clinical efficacy and toxicity of idarubicin (IA regimen) and daunoru-bicin combined with cytarabine (DA regimen) for treating aged patients with AML as induction chemotherapy. The clinical data of 60 newly diagnosed AML aged patients treated with IA or DA regimen were analyzed retrospectively. IA regimen group included 22 patients (8 male and 14 females with median age of 66 yrs), while the DA regimen group included 38 patients (20 males and 18 females with median age of 64 yrs). The complete remission rate, total effective rate and adverse effects after one chemotherapy course were compared. The results showed that the CR rate in IA regimen group was 63.63%, which was significantly higer than that in DA regimen group (31.58%) (P < 0.05). The total effective rate was 63.63% and 36.84% respectively in IA and DA regimen groups, there was significant difference between the two groups (P < 0.05). Both the hematological and non-hematological adverse effects were observed and no |
Author | Xie, Xin-Sheng Gan, Si-Lin Xing, Hai-Zhou Liu, Yan-Fang Tian, Dong-Hua Sun, Hui |
Author_xml | – sequence: 1 givenname: Dong-Hua surname: Tian fullname: Tian, Dong-Hua organization: Zhengzhou Central Hospital Affilated to Zhengzou Universty, Zhengzhou 450007, Henan Province, China – sequence: 2 givenname: Si-Lin surname: Gan fullname: Gan, Si-Lin organization: Department of Hematology, The First Hospital Affiliated to Zhengzhou University, Zhengzhou 450052, Henan Province, China – sequence: 3 givenname: Hai-Zhou surname: Xing fullname: Xing, Hai-Zhou organization: Department of Hematology, The First Hospital Affiliated to Zhengzhou University, Zhengzhou 450052, Henan Province, China – sequence: 4 givenname: Yan-Fang surname: Liu fullname: Liu, Yan-Fang organization: Department of Hematology, The First Hospital Affiliated to Zhengzhou University, Zhengzhou 450052, Henan Province, China – sequence: 5 givenname: Xin-Sheng surname: Xie fullname: Xie, Xin-Sheng organization: Department of Hematology, The First Hospital Affiliated to Zhengzhou University, Zhengzhou 450052, Henan Province, China – sequence: 6 givenname: Hui surname: Sun fullname: Sun, Hui email: sunhui371@medmail.com.cn organization: Department of Hematology, The First Hospital Affiliated to Zhengzhou University, Zhengzhou 450052, Henan Province, China. E-mail:sunhui371@medmail.com.cn |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25338573$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kMtqwzAURLVIadI0v1Duolu7elixtAzpK5DSTbsOsnzlqNiysZwGb_vlNfSxmYFhOANzRWahDUjILaNpLkV295H6GEPKKNUJZyJPOWVZSmVKmZqRxX8-J6sYfUGpFExnVF-SOZdCKJmLBfna1j54a2qwp94M_hMBnZsCO0LrwIfyZH2ooMdmWvNtANf2MBwRAp7rEUpvqtBGLMFUk2xe9tBNGAxDhGIEe8Smndq96UY4--EIuw2YUML9ZkJWvsEQr8mFM3XE1a8vyfvjw9v2Odm_Pu22m33SMb4eElVItEZz56TGwgmVK2MUNyIvucqULhVjObVMW1EYqaxzWmi3lpyztRGY8yW5-eF2p6LB8tD1vjH9ePg7g38DV11m7A |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.7534/j.issn.1009-2137.2014.05.018 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
ExternalDocumentID | 25338573 |
Genre | English Abstract Journal Article |
GroupedDBID | --- -05 2B. 5XA 5XF 92F 92I ACGFS ALMA_UNASSIGNED_HOLDINGS CCEZO CGR CIEJG CUY CVF CW9 ECM EIF EMOBN F5P NPM SV3 TCJ TGQ U1G U5O |
ID | FETCH-LOGICAL-p126t-8b5eca92ff59ebf3878aa82a37d28489d81170c19c3ba58cff939f652216a3e72 |
ISSN | 1009-2137 |
IngestDate | Tue Oct 15 23:51:48 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 5 |
Language | Chinese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p126t-8b5eca92ff59ebf3878aa82a37d28489d81170c19c3ba58cff939f652216a3e72 |
PMID | 25338573 |
ParticipantIDs | pubmed_primary_25338573 |
PublicationCentury | 2000 |
PublicationDate | 2014-Oct |
PublicationDateYYYYMMDD | 2014-10-01 |
PublicationDate_xml | – month: 10 year: 2014 text: 2014-Oct |
PublicationDecade | 2010 |
PublicationPlace | China |
PublicationPlace_xml | – name: China |
PublicationTitle | Zhongguo shi yan xue ye xue za zhi |
PublicationTitleAlternate | Zhongguo Shi Yan Xue Ye Xue Za Zhi |
PublicationYear | 2014 |
SSID | ssib005319409 ssib016118918 ssib010518015 ssj0058540 ssib001103677 ssib051368700 |
Score | 2.057936 |
Snippet | This study was aimed to explore the clinical efficacy and toxicity of idarubicin (IA regimen) and daunoru-bicin combined with cytarabine (DA regimen) for... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 1282 |
SubjectTerms | Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cytarabine - administration & dosage Female Humans Idarubicin - administration & dosage Induction Chemotherapy Leukemia, Myeloid, Acute - drug therapy Male Middle Aged Retrospective Studies |
Title | Clinical curative efficacy of inducing remission for the newly diagnosed aged AML patients by chemotherapy with IA and DA regimens |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25338573 |
Volume | 22 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBabFkovpaXvF3PIzTitZcuWjyZpuilpTgksvQRZj6wh-6C7hu4e-6_67zqyJK8JaWh78S4Slleej9E3s6NPhOxroQtW5ybOVK0wQGE8FlykcSaTnCpV8tx0Vb5n-fgi-zJhk9Ho16BqqV3XB3J7676S_7EqtqFd7S7Zf7BsPyg24He0L17Rwnj9Kxsfhm2NsvUC3toqQtgT3DslCNVKmwn4bs90Ww1rCpFLX29s3tWW2SHlRKeiourraZBZXVlWiuac-f1ZG5evPalc5XIV2fMcZtpn-jy3_TZdzK-u2kW0mjbRBv3Gj1ZHG919bEW0nTZ9mqBxadcjvCEet_3K8NlnY5v4tOlBO_GnroxFE-Mj2tB-2rTd-iHm8bHw669PXyRZXwgXPK79d4YmTvkluGRKB9BjA_-Kqym9zfFj0JV1jt-OedCPaUv3MqfMyoe3oRmXsw4UFOkuZ-40lbt7b8hyh649sldw61rPBmki5FTpUCfQOrpsp5OGnDbhAx6GrDvh5Y4ksCTNeaeb6CgFhnRuZ2-Y1wOy7yf94a4pW6Vr_zNvRE0dezp_TB75sAcqh-EnZLSdPiU_A34h4BcCfmFhIOAXevwC4hcQkdDhF3r8gsUvIH4h4BfqDQzxCxa_cFIB4heOKgj4fUYujj-dH45jfyZIvExovo55zbQUJTWGlbo2KS-4EJyKtFBItHip7MbpjzIpZVoLxqUxZVqaHKOMJBepLuhzcm--mOuXBOqSKi7rnKkiyyTTvDRMUmW19LXOmHlFXrhXdrl0wi-X4WW-_mPPG_JwB_K35L5BT6PfIW1d1-87iPwGlxWNWQ |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+curative+efficacy+of+inducing+remission+for+the+newly+diagnosed+aged+AML+patients+by+chemotherapy+with+IA+and+DA+regimens&rft.jtitle=Zhongguo+shi+yan+xue+ye+xue+za+zhi&rft.au=Tian%2C+Dong-Hua&rft.au=Gan%2C+Si-Lin&rft.au=Xing%2C+Hai-Zhou&rft.au=Liu%2C+Yan-Fang&rft.date=2014-10-01&rft.issn=1009-2137&rft.volume=22&rft.issue=5&rft.spage=1282&rft_id=info:doi/10.7534%2Fj.issn.1009-2137.2014.05.018&rft_id=info%3Apmid%2F25338573&rft_id=info%3Apmid%2F25338573&rft.externalDocID=25338573 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1009-2137&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1009-2137&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1009-2137&client=summon |